Abstract-The stimulation of ␤-adrenoceptors in cardiac cells results in a rapid loss of cellular Mg 2ϩ . Because insulin physiologically counteracts several of the cellular effects mediated by the activation of ␤-adrenoceptors and the elevation of cytosolic cAMP levels, we investigated whether insulin administration could prevent Mg 2ϩ mobilization from rat hearts and ventricular myocytes. Rat hearts were perfused in a retrograde Langendorff system, and the changes in extracellular Mg 2ϩ were measured by atomic absorbance spectrophotometry. Pretreatment of the hearts with 6 nmol/L insulin completely prevented the Mg 2ϩ extrusion induced by the ␤-adrenergic agonist isoproterenol. 
Abstract-The stimulation of ␤-adrenoceptors in cardiac cells results in a rapid loss of cellular Mg 2ϩ . Because insulin physiologically counteracts several of the cellular effects mediated by the activation of ␤-adrenoceptors and the elevation of cytosolic cAMP levels, we investigated whether insulin administration could prevent Mg 2ϩ mobilization from rat hearts and ventricular myocytes. Rat hearts were perfused in a retrograde Langendorff system, and the changes in extracellular Mg 2ϩ were measured by atomic absorbance spectrophotometry. Pretreatment of the hearts with 6 nmol/L insulin completely prevented the Mg 2ϩ extrusion induced by the ␤-adrenergic agonist isoproterenol. Furthermore, the administration of insulin per se induced an accumulation of Mg 2ϩ by the heart. This accumulation was small but detectable in the presence of 25 n recent years, a large number of reports have indicated that the selective stimulation of ␤-adrenoceptors 1-9 results in a marked extrusion of cellular Mg 2ϩ from cardiac myocytes, [1] [2] [3] hepatocytes, 4 -6 and other cell types [7] [8] [9] into the extracellular compartment. In addition, the infusion of isoproterenol or catecholamine results in a 15% to 20% increase in the total serum Mg 2ϩ level in the anesthetized rat. 10, 11 At the cellular level, Mg 2ϩ extrusion can be elicited by the administration of forskolin 2, 4 or cell-permeant cAMP analogues (eg, 8-bromo-cAMP) 2,4 -9 and be inhibited by the administration of Rp-cAMP, 7 a cell-permeant blocking agent specific for protein kinase A. Taken together, these results support the idea that Mg 2ϩ extrusion is mediated via a cAMP-dependent process, most likely the phosphorylation of a specific Mg 2ϩ transporter. 9 Experimental evidence suggests a role for insulin in regulating cellular or tissue Mg 2ϩ content. Our laboratory has recently reported that because of its ability to prevent cAMP production 12 and accelerate cAMP catabolism via phosphodiesterase, 13 insulin can effectively modulate the extrusion of Mg 2ϩ induced by ␤-adrenergic agonists in liver cells. 6 In addition, evidence has been provided indicating that insulin increases cytosolic free [Mg 2ϩ ] in beta pancreatic islets, 14 3T3 fibroblasts, 15 and platelets 16 by promoting an entry of Mg 2ϩ across the plasma membrane and/or a release of Mg 2ϩ from an intracellular organelle(s). Last, a marked decrease in cellular Mg 2ϩ content has been observed in diabetes types I and II 17-19 both in humans 17, 18 and animals, 19 and this decrease has been suggested to be a possible cause of the long-term complications associated with diabetes. 20 In the present study, the ability of insulin to modulate cellular Mg 2ϩ in cardiac myocytes was investigated. 
Materials and Methods

Chemicals
Collagenase (CLS-1) was from Worthington. [ 3 H]2-Deoxyglucose was from Amersham. All other chemicals were from Sigma Chemical Co. Whatman glass fiber filters were from Fisher.
Rat Heart Perfusion
Male Sprague-Dawley rats (250 g body weight) were anesthetized by intraperitoneal injection of sodium pentobarbital. The heart was removed and perfused in a Langendorff system at a flow rate of 7 mL/min with a medium containing (mmol/L) NaCl 120, KCl 2 or insulin was added to the perfusion medium.
In the experiments performed in the absence of extracellular glucose, 5 mmol/L pyruvate and 5 mmol/L lactate were added to the perfusion medium. Alternatively, pyruvate and lactate were added to the perfusion medium in addition to glucose. Cytochalasin B or phloretin was dissolved in the perfusion medium 5 minutes before insulin administration.
Aliquots of the perfusate were collected every 30 seconds, and the Mg 2ϩ content was measured by atomic absorbance spectrophotometry in a Perkin-Elmer 3100 spectrophotometer after proper dilution. Net Mg 2ϩ accumulation was estimated as described previously. 21 At the end of the experiment, the heart was homogenized in 10% HNO 3 and extracted overnight. The Mg 2ϩ content in the acid supernatant was measured by atomic absorbance spectrophotometry as described previously. 3 
Isolation of Cardiac Ventricular Myocytes and Determination of Mg 2؉ Accumulation
Cardiac ventricular myocytes were isolated by collagenase digestion as described by De Young et al. 22 An aliquot of cell suspension was washed at 600g for 1 minute and transferred into the incubation medium described previously, in the presence of varying concentrations of extracellular Mg 2ϩ or glucose. Mg 2ϩ accumulation into the cells was determined as reported previously. 3 
Determination of Glucose Transport
For the experiments in perfused hearts, 0.2 mCi/mL [ 3 H]2-deoxyglucose was added to the perfusion medium. Half-milliliter aliquots of the perfusate were collected in duplicate and transferred in scintillation vials to measure the radioactivity by ␤-scintillation counting in a Beckman LS7000 counter. At the end of the perfusion, the heart was homogenized in 10% HNO 3 and extracted overnight. The radioactivity accumulated into the tissue was measured by ␤-scintillation counting in aliquots of the homogenate.
For the experiments in isolated myocytes, the cells were incubated as previously reported, in the presence of 0.2 mCi/mL [ 3 H]2-deoxyglucose. After insulin administration, glucose accumulation was determined, as reported previously, 23 as the radioactivity retained onto glass fiber filters (NF Whatman, pore size 0.25 m).
Protein was assessed by the procedure of Lowry et al 24 with bovine serum albumin used as a standard.
Statistical Analysis
The data were reported as meanϮSE. Data were first analyzed by 1-way ANOVA. Multiple means were then compared by the Tukey multiple comparison test, which was performed with a q value established for significance at PϽ0.05.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results
The administration of 1 or 10 mol/L isoproterenol to rat hearts perfused in a Langendorff system resulted in a detectable increase in heart contractility (not shown) and in a marked extrusion of Mg 2ϩ from the organ into the perfusate ( Figure 1A ). Mg 2ϩ efflux became evident within 2 minutes after the addition of the ␤-adrenergic agonist to the perfusion medium and persisted for an additional 5 minutes before returning toward basal levels. The time course of these changes was independent of the dose and persistence of the agonist in the perfusion medium, the rate of contractility elicited by the adrenergic agonist, and [Mg 2ϩ ] o , as already reported. 2, 3 Isoproterenol-induced Mg 2ϩ extrusion was also observed when the concentration of Mg 2ϩ in the perfusate was increased to 100 and 250 mol/L. Despite the high noise-tosignal ratio observed under these experimental conditions, the net amount of Mg 2ϩ extruded from the heart was similar Figure 3B , the net Mg 2ϩ accumulation by the perfused heart during 8 minutes of insulin administration is reported as the total amount of Mg 2ϩ disappearing from the perfusate. The net Mg 2ϩ accumulation was accounted for by Ϸ500 to 600 nmol/g heart for [ A similar inhibitory effect of insulin on isoproterenol-or cAMP-induced Mg 2ϩ extrusion has been observed in perfused liver. 6 However, insulin per se did not induce any detectable Mg 2ϩ uptake into liver cells, regardless of the [Mg 2ϩ ] o used. 6 One notable difference between cardiac and liver cell metabolism is the different class of glucose transporter present in the plasma membrane, namely, Glut1 and Glut4 in cardiac cells 25 and Glut 2 in hepatocytes. 25 Glut4 transporters (and Glut1 to a lesser extent), 26 but not Glut2, 25 are recruited to the sarcolemma by insulin administration. Therefore, we next investigated the possibility that glucose transport is involved in mediating the accumulation of Mg 2ϩ induced by insulin. The requirement of glucose transport for Mg 2ϩ accumulation is supported by the data reported in Figure 4 . In the presence of 50 mol/L [Mg 2ϩ ] o , the absence of glucose in the perfusate (replaced with lactate and pyruvate, Figure 4B ) completely prevented the insulin-mediated Mg 2ϩ accumulation ( Figure 4A ). To exclude the possibility that the lack of Mg 2ϩ accumulation observed under these experimental conditions could be attributable to the sudden change in metabolic substrate, in a separate set of experiments, 5 mmol/L pyruvate and 5 mmol/L lactate were introduced into the perfusion medium at the start, in addition to glucose. Glucose was removed at the time of insulin administration, to be reintroduced after hormone removal, but pyruvate and lactate were maintained throughout the experimental protocol. Also, under these experimental conditions, insulin administration did not result in an accumulation of Mg 2ϩ in the heart (total tissue Mg 2ϩ content was 64.0Ϯ6.4 versus 61.7Ϯ5.4 nmol Figure 4C ) and an accumulation in the heart (total tissue Mg 2ϩ content was 70.8Ϯ2.5 versus 60.8Ϯ3.4 nmol Mg 2ϩ /mg protein Ϫ1 in the presence or in the absence of insulin, respectively).
In a separate set of experiments, cytochalasin B and phloretin were used as glucose transport inhibitors. Whereas cytochalasin B blocks the translocation of glucose transporters to the plasma membrane by disrupting cytoskeleton integrity, phloretin inhibits glucose transport operation at the plasma membrane by interacting at the extracellular site of the transporter. 23, 25 When 1 mol/L cytochalasin B or 10 mol/L phloretin was added to the perfusate in the presence of glucose, the insulin-induced Mg 2ϩ accumulation in the heart was almost completely inhibited ( Figure 5) . Figure 4A . Presently, we have no explanation for this discrepancy. The presence of a synergism between glucose and Mg 2ϩ accumulation is further corroborated by the results reported in Figure 7 . Because nonphosphorylated glucose can cross the sarcolemma in either direction, [ 3 H]2-deoxyglucose, which remains trapped in the cytosol after the phosphorylation by hexokinase, 25 was used to quantify the amount of glucose accumulated by cardiac ventricular myocytes after 5 minutes of stimulation by 10 mU/mL (6 nmol/L) insulin. Cardiac ventricular myocytes rather than perfused hearts were used to exclude possible artifacts related to perfusion flow rate and to cell heterogeneity. The data, reported in Figure 7A, Figure 7B ). Based on the total cellular Mg 2ϩ content of cardiac ventricular myocytes, these values account for increases of 10% and 22% in total Mg 2ϩ content, respectively. After it had been determined that the presence of extracellular glucose or the operation of glucose transporter is necessary to observe insulin-induced Mg 2ϩ accumulation, rat hearts were perfused in the presence of pyruvate and lactate but in the absence of glucose and stimulated by 10 mol/L isoproterenol and 10 mU/mL insulin to determine whether the effect of insulin on the ␤-adrenoceptor-mediated Mg 2ϩ extrusion observed in Figures 1 and 2 could be ascribed to an inhibitory effect on ␤-adrenergic signaling 12, 13 and/or to a stimulated accumulation of Mg 2ϩ into the heart. As Figure 8A shows, in the presence of 50 mol/L [Mg 2ϩ ] o but in the absence of extracellular glucose, insulin was still able to block the extrusion of Mg 2ϩ elicited by isoproterenol infusion. By contrast, in the presence of glucose, the administration of insulin before adrenergic agonist infusion resulted in an accumulation of Mg 2ϩ that could not be reverted by the subsequent infusion of isoproterenol ( Figure 8B ).
Discussion
The administration of ␤-adrenergic agonists to cardiac cells elicits a marked extrusion of cellular Mg 2ϩ in the extracellular compartment 1-3 via an increase in cAMP and the activation of a specific Na ϩ -Mg 2ϩ exchanger. 27, 28 Recently, we have reported that insulin can modulate Mg 2ϩ content in liver cells by preventing the ␤-adrenoceptor-mediated Mg 2ϩ mobilization from the cell. 6 The present study, undertaken to investigate whether insulin has a similar modulatory role in cardiac cells, provides several novel observations. First, it provides evidence for a role of insulin in preserving Mg 2ϩ content in cardiac cells by preventing the Mg 2ϩ mobilization induced by ␤-adrenoceptor stimulation. Second, it indicates that insulin induces an accumulation of Mg 2ϩ into cardiac cells through a transport mechanism that is linked to the operation of glucose transporter in the cardiac sarcolemma. Third and most important, it suggests that Mg 2ϩ is indispensable for the accumulation of 
Effect of Insulin on Cellular Mg 2؉ Homeostasis
The administration of insulin before isoproterenol (Figure 1 ) or cAMP addition (not shown) or after ␤-agonist administration ( Figure 2) can completely prevent the extrusion of Mg 2ϩ elicited via activation of the ␤-adrenergic signaling pathway. These effects of insulin can be explained by the ability of insulin to desensitize ␤-adrenoceptors 12,29 at the cell membrane and stimulate calmodulin-dependent phosphodiesterase, 13 thereby limiting the production and inducing a more rapid degradation of cellular cAMP. Overall, these results are consistent with the inhibitory effect observed previously in the perfused liver 6 and would indicate a more general and physiological role of insulin at modulating ␤-adrenoceptormediated Mg 2ϩ extrusion in various tissues. At variance with the observations involving liver cells, 6 insulin induces an entry of Mg 2ϩ into cardiac cells. This accumulation can be reliably detected when [Mg 2ϩ ] o is progressively increased from 25 to 1000 mol/L Mg 2ϩ . Interestingly, under conditions in which [Mg 2ϩ ] o is Ͼ5 mol/L, insulin-induced Mg 2ϩ accumulation appears to prevail over isoproterenol-stimulated Mg 2ϩ extrusion (Figures 2 and 8B) . Consistent with the observations in liver cells 6 and the modality of action on ␤-adrenoceptors 12,29 and phosphodiesterase, 13 insulin still exerts a regulatory role on cellular Mg 2ϩ homeostasis under conditions in which Mg 2ϩ accumulation is prevented (ie, absence of extracellular glucose; Figure 8A ). This may suggest that insulin and ␤-adrenergic agonists regulate cellular Mg 2ϩ homeostasis by activating distinct Mg 2ϩ transport mechanisms and that insulin can inhibit the Mg 2ϩ extrusion mechanism as well as activate the Mg 2ϩ entry pathway. Because of the novelty of this observation, the physiological conditions that determine the modality of insulin action on cardiac Mg 2ϩ homeostasis require further investigation.
Because insulin does not stimulate Mg 2ϩ accumulation in the perfused liver 6 regardless of [Mg 2ϩ ] o in the perfusion medium, cardiac but not liver cells must possess a specific entry mechanism activated by insulin. One of the main differences between cardiac and liver cells is the different class of glucose transporter present in the plasma membrane of these 2 cell types. In cardiac myocytes, insulin induces glucose accumulation by recruiting Glut4 (10-to 20-fold increase) and Glut1 transporters (2-fold increase) from a preconstituted intracellular pool to the sarcolemma. 26 The consequence of this recruitment is that glucose accumulation into cardiac myocytes increases severalfold and in a manner that is not simply proportional to the number of new transporters expressed in the sarcolemma. 30 By contrast, liver cells possess a distinct glucose transporter (Glut2) that is not affected in number and operation by insulin. 25 
Involvement of Glucose Transport in Insulin-Mediated Mg 2؉ Accumulation
The results obtained in the absence of external glucose or in the presence of the inhibitors of glucose transport, cytochalasin B and phloretin, are consistent with the idea that insulin-induced Mg 2ϩ accumulation requires operation and/or internalization of glucose transporters. Because insulin administration increases the expression of Glut4 to a great degree and Glut1 only marginally in the sarcolemma, it is conceivable that Glut4 is the main class of glucose transporters involved in Mg 2ϩ accumulation. Support for this hypothesis is provided by the effect of glucose transport inhibitors. Whereas phloretin blocks both Glut1 and Glut4 in the sarcolemma by interacting at the extracellular site of the transporter, cytochalasin B (by disrupting cytoskeletal integrity) mainly affects Glut4, by preventing the recruitment of this transporter to the sarcolemma after insulin administration. In addition, Mg 2ϩ accumulation requires a minimal extracellular glucose concentration of 2 mmol/L to occur, which falls well within the K m of the Glut4 transporter. 25 However, because Mg 2ϩ accumulation increases proportionally with the extracellular glucose concentration, the additional involvement of the Glut1 transporter (with a higher K m 25 ) cannot be altogether excluded. Last, it is interesting to note that insulin and isoproterenol stimulate an accumulation and an extrusion of Mg 2ϩ , respectively, whereas they both induce a glucose accumulation in cardiac cells. Because insulin primarily activates Glut4 and isoproterenol activates Glut 1, 25 further indirect evidence is provided for the role of Glut4 in Mg 2ϩ accumulation. Our data do not clearly indicate whether Mg 2ϩ is cotransported with glucose or whether the cation enters the cell through a transport pathway distinct from the glucose trans- porters. However, the inhibitory effect of cytochalasin B or phloretin suggests that the Mg 2ϩ entry mechanism is activated by insulin indirectly via glucose transporter operation. Moreover, it appears that glucose reintroduction can induce Mg 2ϩ accumulation even after insulin is removed from the system ( Figure 4A ). Most likely, this phenomenon is due to the persistence of an activated Glut4 transporter in the sarcolemma that is able to transport glucose after its reintroduction. In view of the fact that a glucose-triggered Mg 2ϩ accumulation has been observed in pancreatic beta cells, 31 
Evidence for Role of Cellular Mg 2؉ in Mediating Effects of Insulin
A dependence of insulin-induced glucose transport in rat cardiac myocytes on intracellular Mg 2ϩ has been reported by Eckel et al. 32 The authors observed that insulin-stimulated glucose entry was completely abolished when EDTA buffer was used on A23187-treated myocytes 32 and proposed an involvement of Mg 2ϩ in insulin signaling. Whether this involvement is at the level of Mg 2ϩ -dependent hexokinase, cytoskeletal elements, or other intracellular enzymes involved in the translocation of glucose transporter to and from the sarcolemma is presently undefined. Evidence has been provided for a reduced autophosphorylation of insulin receptors and a reduced phosphorylation of insulin receptor-related kinases in Mg 2ϩ -deficient animals 33 and for significant alterations in glycemia and glucose utilization in rats after a long-term Mg 2ϩ -deficient diet. 34 Altogether, these observations strongly support a role of Mg 2ϩ in modulating insulin response and cellular glucose utilization.
Conclusions
At the present time, we can only speculate about the physiological implication of Mg 2ϩ accumulation in the heart. It is conceivable that Mg 2ϩ plays 2 distinct though not mutually exclusive roles at the level of glucose entry and glucose utilization. As for glucose entry, Mg 2ϩ may modulate the activity of cytoskeleton and kinases involved in the translocation of glucose transporters 35 or regulate allosterically glucose transport operation by changing the V max of the transporter. A similar effect of extracellular Mg 2ϩ on the inositol transporter in intestinal cells has been reported. 36 If corroborated by experimental evidence, either of these possibilities may explain why, after insulin stimulation, the rate of glucose transport increases by Ϸ20-fold versus the expected 10-fold increase calculated on the basis of the number of Glut4 recruited to the sarcolemma. 30 Alternatively, Mg 2ϩ entry may be required to favor glucose utilization in cardiac cells, because many of the glycolytic enzymes, including hexokinase, are Mg 2ϩ dependent to varying degrees. Our recent observation 37 that Mg 2ϩ plays a regulatory role in the activity of several mitochondrial dehydrogenases supports the hypothesis that Mg 2ϩ accumulated into the cell may be rapidly redistributed from the cytosol into the mitochondria or other organelles and regulate rates of respiration or concentrations of substrates necessary for specific metabolic pathways.
Together with previous evidence in the literature, the data reported in the present study indicate a close link between glucose transport and Mg 2ϩ accumulation in cardiac ventricular myocytes. Although this link may be present in other cell types, it may be predominant in the heart, in which insulin modulates the operation of glucose transporters. Furthermore, indirect support for this link is provided by the observation that cellular Mg 2ϩ levels and glucose utilization are markedly reduced in diabetic humans and animals. The relevance of this relation under both physiological and pathological conditions remains to be elucidated.
